Allergy and Immunology · Sacramento, CA
NPI
1356792022
Since 2016
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4860 Y St
Sacramento, CA, 95817
Phone (916) 734-8046
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
431 services
Medicare patients, 2024
137
Average age 70
Drug cost, 2024
$364K
625 prescriptions
Company payments, 2023
$17.71
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vinay P Goswamy was code 99215 (office e&m - established), 46 times for 33 patients. In total Vinay P Goswamy billed 431 services in 22 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 46 | 33 | $106.62 | $4,904 |
| 99214 Office E&M - Established | Facility | 41 | 33 | $76.37 | $3,131 |
| 99215 Office E&M - Established | Office | 32 | 21 | $146.36 | $4,684 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 32 | 30 | $13.42 | $429 |
| 99214 Office E&M - Established | Office | 31 | 27 | $97.58 | $3,025 |
| 99205 Office E&M - New | Facility | 21 | 21 | $141.48 | $2,971 |
| 99204 Office E&M - New | Facility | 19 | 19 | $65.63 | $1,247 |
| 99205 Office E&M - New | Office | 19 | 19 | $153.92 | $2,924 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 11 | $13.45 | $161 |
| 99204 Office E&M - New | Office | 11 | 11 | $103.72 | $1,141 |
By year: 2022 $1,602 for 157 services; 2023 $23K for 240 services; 2024 $28K for 431 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vinay P Goswamy prescribed most often to Medicare patients was Azelastine-Fluticasone (Azelastine/Fluticasone), with 152 prescriptions and refills. In total Vinay P Goswamy wrote 625 Medicare prescriptions that cost $364K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine-Fluticasone Azelastine/Fluticasone | 152 | 219 | 50 | $21K |
| Fluticasone Propionate Generic | 41 | 61 | 21 | $547 |
| Azelastine Hcl Generic | 39 | 64 | 21 | $936 |
| Ipratropium Bromide Generic | 32 | 47 | 16 | $1,282 |
| Dupixent Pen Dupilumab | 31 | 35 | Under 11 | $127K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 28 | 32 | 15 | $751 |
| Symbicort Budesonide/Formoterol Fumarate | 23 | 29 | 11 | $8,538 |
| Olopatadine Hcl Generic | 22 | 32 | 13 | $1,314 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 21 | 33 | Under 11 | $20K |
| Dulera Mometasone/Formoterol | 20 | 20 | Under 11 | $7,406 |
| Omeprazole Generic | 20 | 27 | Under 11 | $182 |
| Breyna Budesonide/Formoterol Fumarate | 20 | 24 | Under 11 | $4,994 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 13 | 16 | Under 11 | $2,225 |
| Montelukast Sodium Generic | 12 | 18 | Under 11 | $68.08 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 11 | 11 | Under 11 | $2,812 |
Brand drugs: 223 claims; generic drugs: 402 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Vinay P Goswamy $17.71 ($17.71 in general payments such as food, travel and fees) from 1 company. The largest payer was Regeneron Healthcare Solutions, Inc. with $17.71.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $17.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.